Reference health
Enzymatic Pathways That Regulate Endocannabinoid Signaling in the Nervous System
183/183 checkable references clean · checked 2026-07-22
Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.
6 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.
The 183 checked references that resolve
resolves10.1126/science.283.5400.401
Unresponsiveness to Cannabinoids and Reduced Addictive Effects of Opiates in CB
<sub>1</sub>
Receptor Knockout Mice
resolves10.1073/pnas.96.10.5780
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice
resolves10.1126/science.1470919
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
resolves10.1016/0006-2952(95)00109-D
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
resolves10.1006/bbrc.1995.2437
2-Arachidonoylgylcerol: A Possible Endogenous Cannabinoid Receptor Ligand in Brain
resolves10.1016/j.chembiol.2007.05.014
Endocannabinoids and Related Compounds: Walking Back and Forth between Plant Natural Products and Animal Physiology
resolves10.1146/annurev.neuro.29.051605.112834
ENDOCANNABINOID-MEDIATED SYNAPTIC PLASTICITY IN THE CNS
resolves10.1098/rspb.1998.0543
A new perspective on cannabinoid signalling: complimentary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain.
resolves10.1523/JNEUROSCI.19-11-04544.1999
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
resolves10.1016/S0026-895X(24)26516-0
Endocannabinoid 2-Arachidonyl Glycerol Is a Full Agonist through Human Type 2 Cannabinoid Receptor: Antagonism by Anandamide
resolves10.1124/mol.55.1.8
Δ<sup>9</sup>-Tetrahydrocannabinol Acts as a Partial Agonist to Modulate Glutamatergic Synaptic Transmission between Rat Hippocampal Neurons in Culture
resolves10.1523/JNEUROSCI.4403-06.2007
Specific Alterations of Extracellular Endocannabinoid Levels in the Nucleus Accumbens by Ethanol, Heroin, and Cocaine Self-Administration
resolves10.1111/j.1460-9568.2007.05900.x
CB1 receptor‐mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus
resolves10.1016/S0083-6729(01)62002-8
Proteins regulating the biosynthesis and inactivation of neuromodulatory fatty acid amides
resolves10.1021/jm058183t
The Endocannabinoid System: Drug Targets, Lead Compounds, and Potential Therapeutic Applications
resolves10.1016/j.plipres.2006.03.003
Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand
resolves10.1146/annurev.biochem.74.082803.133450
STRUCTURE AND FUNCTION OF FATTY ACID AMIDE HYDROLASE
resolves10.1016/0006-2952(93)90486-G
Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
resolves10.1074/jbc.270.40.23823
Partial Purification and Characterization of the Porcine Brain Enzyme Hydrolyzing and Synthesizing Anandamide
resolves10.1016/0005-2760(95)00087-S
Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain
resolves10.1126/science.7770779
Chemical Characterization of a Family of Brain Lipids That Induce Sleep
resolves10.1016/0014-5793(95)01311-3
Two novel classes of neuroactive fatty acid amides are substrates for mouse neuroblastoma ‘anandamide amidohydrolase’
resolves10.1038/384083a0
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
resolves10.1073/pnas.94.6.2238
Molecular characterization of human and mouse fatty acid amide hydrolases
resolves10.1016/S0006-2952(98)00314-1
Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors
resolves10.1111/j.1460-9568.2004.03428.x
Segregation of two endocannabinoid‐hydrolyzing enzymes into pre‐ and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala
resolves10.1021/bi981733n
Comparative Characterization of a Wild Type and Transmembrane Domain-Deleted Fatty Acid Amide Hydrolase: Identification of the Transmembrane Domain as a Site for Oligomerization
resolves10.1016/S1388-1981(99)00124-9
Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme
resolves10.1016/j.jneumeth.2006.10.006
A high throughput fluorescent assay for measuring the activity of fatty acid amide hydrolase
resolves10.1016/j.ab.2006.10.041
Development of highly sensitive fluorescent assays for fatty acid amide hydrolase
resolves10.1126/science.1076535
Structural Adaptations in a Membrane Enzyme That Terminates Endocannabinoid Signaling
resolves10.1093/emboj/21.11.2509
Structure of malonamidase E2 reveals a novel Ser‐cisSer‐Lys catalytic triad in a new serine hydrolase fold that is prevalent in nature
resolves10.1021/bi002578r
Characterization and Manipulation of the Acyl Chain Selectivity of Fatty Acid Amide Hydrolase
resolves10.1021/bi990637z
Chemical and Mutagenic Investigations of Fatty Acid Amide Hydrolase: Evidence for a Family of Serine Hydrolases with Distinct Catalytic Properties
resolves10.1074/jbc.M001607200
Clarifying the Catalytic Roles of Conserved Residues in the Amidase Signature Family
resolves10.1074/jbc.M303922200
Evidence for Distinct Roles in Catalysis for Residues of the Serine-Serine-Lysine Catalytic Triad of Fatty Acid Amide Hydrolase
resolves10.1021/bi991876p
Fatty Acid Amide Hydrolase Competitively Degrades Bioactive Amides and Esters through a Nonconventional Catalytic Mechanism
resolves10.1073/pnas.161191698
Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase
resolves10.1016/j.ejphar.2006.11.002
Assessment of anandamide's pharmacological effects in mice deficient of both fatty acid amide hydrolase and cannabinoid CB1 receptors
resolves10.1159/000087925
Cocaine- and Amphetamine-Related Transcript Is Involved in the Orexigenic Effect of Endogenous Anandamide
resolves10.1016/j.pain.2004.01.022
Mice lacking fatty acid amide hydrolase exhibit a cannabinoid receptor-mediated phenotypic hypoalgesia
resolves10.1073/pnas.0401292101
Functional disassociation of the central and peripheral fatty acid amide signaling systems
resolves10.1126/science.1142265
Attenuation of Allergic Contact Dermatitis Through the Endocannabinoid System
resolves10.1007/s00213-006-0689-4
Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality
resolves10.1016/j.neuropharm.2007.07.005
Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors
resolves10.1093/sleep/27.5.857
Characterization of the Sleep-wake Patterns in Mice Lacking Fatty Acid Amide Hydrolase
resolves10.1038/sj.npp.1301224
Inhibition of Fatty-Acid Amide Hydrolase Accelerates Acquisition and Extinction Rates in a Spatial Memory Task
resolves10.1016/S0960-894X(98)00734-3
Trifluoromethyl ketone inhibitors of fatty acid amide hydrolase: A probe of structural and conformational features contributing to inhibition
resolves10.1016/S0006-2952(96)00830-1
Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase
resolves10.1074/jbc.270.1.445
Inhibition of Macrophage Ca2+-independent Phospholipase A2 by Bromoenol Lactone and Trifluoromethyl Ketones
resolves10.1124/jpet.103.055392
Inhibition of Platelet-Activating Factor (PAF) Acetylhydrolase by Methyl Arachidonyl Fluorophosphonate Potentiates PAF Synthesis in Thrombin-Stimulated Human Coronary Artery Endothelial Cells
resolves10.1016/S0009-3084(02)00150-0
A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation
resolves10.1073/pnas.97.10.5044
Exceptionally potent inhibitors of fatty acid amide hydrolase: The enzyme responsible for degradation of endogenous oleamide and anandamide
resolves10.1124/jpet.104.069401
Reversible Inhibitors of Fatty Acid Amide Hydrolase That Promote Analgesia: Evidence for an Unprecedented Combination of Potency and Selectivity
resolves10.1038/sj.bjp.0706699
Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms
resolves10.1016/j.chembiol.2005.08.011
Mechanism of Carbamate Inactivation of FAAH: Implications for the Design of Covalent Inhibitors and In Vivo Functional Probes for Enzymes
resolves10.1038/sj.bjp.0706348
Inhibitors of fatty acid amide hydrolase reduce carrageenan‐induced hind paw inflammation in pentobarbital‐treated mice: comparison with indomethacin and possible involvement of cannabinoid receptors
resolves10.1038/sj.bjp.0706510
Actions of the FAAH inhibitor URB597 in neuropathic and inflammatory chronic pain models
resolves10.1124/jpet.107.119941
The Fatty Acid Amide Hydrolase Inhibitor URB597 (Cyclohexylcarbamic Acid 3′-Carbamoylbiphenyl-3-yl Ester) Reduces Neuropathic Pain after Oral Administration in Mice
resolves10.1523/JNEUROSCI.3326-06.2006
Analgesic Effects of Fatty Acid Amide Hydrolase Inhibition in a Rat Model of Neuropathic Pain
resolves10.1073/pnas.0509591102
Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis
resolves10.1124/jpet.106.101287
Pharmacological Evaluation of Cannabinoid Receptor Ligands in a Mouse Model of Anxiety: Further Evidence for an Anxiolytic Role for Endogenous Cannabinoid Signaling
resolves10.1016/j.biopsych.2006.12.001
Antidepressant-like Activity of the Fatty Acid Amide Hydrolase Inhibitor URB597 in a Rat Model of Chronic Mild Stress
resolves10.1161/01.CIR.0000143230.23252.D2
Endocannabinoids Acting at Cannabinoid-1 Receptors Regulate Cardiovascular Function in Hypertension
resolves10.1152/ajpheart.00373.2007
Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase
resolves10.1007/s00213-007-0970-1
The effect of cannabidiol and URB597 on conditioned gaping (a model of nausea) elicited by a lithium-paired context in the rat
resolves10.1124/jpet.104.078980
Characterization of the Fatty Acid Amide Hydrolase Inhibitor Cyclohexyl Carbamic Acid 3′-Carbamoyl-biphenyl-3-yl Ester (URB597): Effects on Anandamide and Oleoylethanolamide Deactivation
resolves10.1016/j.neuropharm.2006.11.009
Fatty acid amide hydrolase inhibitors display broad selectivity and inhibit multiple carboxylesterases as off-targets
resolves10.1021/bi701378g
Novel Mechanistic Class of Fatty Acid Amide Hydrolase Inhibitors with Remarkable Selectivity
resolves10.1016/j.bcp.2005.01.012
A spectrophotometric assay for fatty acid amide hydrolase suitable for high-throughput screening
resolves10.1016/j.cbpa.2003.11.004
The development and application of methods for activity-based protein profiling
resolves10.1038/nbt826
Discovering potent and selective reversible inhibitors of enzymes in complex proteomes
resolves10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4
Direct visualization of serine hydrolase activities in complex proteomes using fluorescent active site-directed probes
resolves10.1016/j.bmcl.2004.12.085
Discovery of an exceptionally potent and selective class of fatty acid amide hydrolase inhibitors enlisting proteome-wide selectivity screening: concurrent optimization of enzyme inhibitor potency and selectivity
resolves10.1021/jm049614v
Discovery of a Potent, Selective, and Efficacious Class of Reversible α-Ketoheterocycle Inhibitors of Fatty Acid Amide Hydrolase Effective as Analgesics
resolves10.1021/bi0480335
Assignment of Endogenous Substrates to Enzymes by Global Metabolite Profiling
resolves10.1021/bi0608008
A FAAH-Regulated Class of <i>N-</i>Acyl Taurines That Activates TRP Ion Channels
resolves10.1021/bi0608010
Structure-Based Design of a FAAH Variant That Discriminates between the <i>N</i>-Acyl Ethanolamine and Taurine Families of Signaling Lipids
resolves10.1038/372686a0
Formation and inactivation of endogenous cannabinoid anandamide in central neurons
resolves10.1126/science.277.5329.1094
Functional Role of High-Affinity Anandamide Transport, as Revealed by Selective Inhibition
resolves10.1046/j.1471-4159.1997.69020631.x
Accumulation of <i>N</i>‐Arachidonoylethanolamine (Anandamide) into Cerebellar Granule Cells Occurs via Facilitated Diffusion
resolves10.1111/j.1472-8206.2006.00442.x
The cannabinoid system and its pharmacological manipulation – a review, with emphasis upon the uptake and hydrolysis of anandamide
resolves10.1074/jbc.M003161200
The Cellular Uptake of Anandamide Is Coupled to Its Breakdown by Fatty-acid Amide Hydrolase
resolves10.1124/mol.59.6.1369
Role of Fatty Acid Amide Hydrolase in the Transport of the Endogenous Cannabinoid Anandamide
resolves10.1073/pnas.0507470102
Identification of a high-affinity binding site involved in the transport of endocannabinoids
resolves10.1046/j.1471-4159.2000.0742597.x
Structure—Activity Relationships Among <i>N</i>‐Arachidonylethanolamine (Anandamide) Head Group Analogues for the Anandamide Transporter
resolves10.1038/sj.bjp.0706253
Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate
resolves10.1021/ja062999h
The Putative Endocannabinoid Transport Blocker LY2183240 Is a Potent Inhibitor of FAAH and Several Other Brain Serine Hydrolases
resolves10.1007/s10571-006-9072-6
Pharmacological Characterization of Endocannabinoid Transport and Fatty Acid Amide Hydrolase Inhibitors
resolves10.1021/bi049395f
Comparison of Anandamide Transport in FAAH Wild-Type and Knockout Neurons: Evidence for Contributions by both FAAH and the CB1 Receptor to Anandamide Uptake
resolves10.1074/jbc.M509721200
Anandamide Uptake Is Consistent with Rate-limited Diffusion and Is Regulated by the Degree of Its Hydrolysis by Fatty Acid Amide Hydrolase
resolves10.1073/pnas.0400997101
Anandamide transport is independent of fatty-acid amide hydrolase activity and is blocked by the hydrolysis-resistant inhibitor AM1172
resolves10.1074/jbc.M407250200
A Role for Caveolae/Lipid Rafts in the Uptake and Recycling of the Endogenous Cannabinoid Anandamide
resolves10.1074/jbc.M411642200
Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal Cells
resolves10.1073/pnas.082235799
A missense mutation in human fatty acid amide hydrolase associated with problem drug use
resolves10.1093/hmg/ddh216
Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use
resolves10.1002/ajmg.b.30491
The fatty acid amide hydrolase C385A (P129T) missense variant in cannabis users: Studies of drug use and dependence in caucasians
resolves10.1016/j.neulet.2004.11.050
A nonsynonymous polymorphism in the human fatty acid amide hydrolase gene did not associate with either methamphetamine dependence or schizophrenia
resolves10.1097/YPG.0b013e32809913d8
Association study between alcoholism and endocannabinoid metabolic enzyme genes encoding fatty acid amide hydrolase and monoglyceride lipase in a Japanese population
resolves10.1038/sj.ijo.0802954
Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH)
resolves10.1007/s00109-006-0139-0
The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5,801 whites
resolves10.1055/s-2007-977694
Genetic Variation in Two Proteins of the Endocannabinoid System and their Influence on Body Mass Index and Metabolism under Low Fat Diet
resolves10.1074/jbc.M606646200
A Second Fatty Acid Amide Hydrolase with Variable Distribution among Placental Mammals
resolves10.1074/jbc.M106261200
Purification and Characterization of an Acid Amidase Selective for N-Palmitoylethanolamine, a Putative Endogenous Anti-inflammatory Substance
resolves10.1074/jbc.M413473200
Molecular Characterization of N-Acylethanolamine-hydrolyzing Acid Amidase, a Novel Member of the Choloylglycine Hydrolase Family with Structural and Functional Similarity to Acid Ceramidase
resolves10.1042/bj20031695
N-Cyclohexanecarbonylpentadecylamine: a selective inhibitor of the acid amidase hydrolysing N-acylethanolamines, as a tool to distinguish acid amidase from fatty acid amide hydrolase
resolves10.1016/j.bbalip.2005.08.010
Involvement of N-acylethanolamine-hydrolyzing acid amidase in the degradation of anandamide and other N-acylethanolamines in macrophages
resolves10.1006/geno.1999.5953
Molecular Cloning and Characterization of a Human cDNA and Gene Encoding a Novel Acid Ceramidase-like Protein
resolves10.1016/j.bbalip.2007.03.005
Predominant expression of lysosomal N-acylethanolamine-hydrolyzing acid amidase in macrophages revealed by immunochemical studies
resolves10.1111/j.1471-4159.2007.04956.x
Manipulation of fatty acid amide hydrolase functional activity alters sensitivity and dependence to ethanol
resolves10.1038/sj.npp.1301274
Role of Endocannabinoids in Alcohol Consumption and Intoxication: Studies of Mice Lacking Fatty Acid Amide Hydrolase
resolves10.1016/S0140-6736(00)02115-2
Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage
resolves10.1093/molehr/8.2.188
Low fatty acid amide hydrolase and high anandamide levels are associated with failure to achieve an ongoing pregnancy after IVF and embryo transfer
resolves10.1016/S0021-9258(17)44667-9
Metabolism of N-acylethanolamine phospholipids by a mammalian phosphodiesterase of the phospholipase D type.
resolves10.1523/JNEUROSCI.16-12-03934.1996
Biosynthesis of an Endogenous Cannabinoid Precursor in Neurons and its Control by Calcium and cAMP
resolves10.1523/JNEUROSCI.17-04-01226.1997
Occurrence and Biosynthesis of Endogenous Cannabinoid Precursor,<i>N</i>-Arachidonoyl Phosphatidylethanolamine, in Rat Brain
resolves10.1074/jbc.M306642200
Molecular Characterization of a Phospholipase D Generating Anandamide and Its Congeners
resolves10.1021/bi060163l
Inactivation of <i>N</i>-Acyl Phosphatidylethanolamine Phospholipase D Reveals Multiple Mechanisms for the Biosynthesis of Endocannabinoids
resolves10.1111/j.1471-4159.1984.tb12750.x
Catabolism of <i>N</i>‐Acylethanolamine Phospholipids by Dog Brain Preparations
resolves10.1074/jbc.M512359200
Functional Analysis of the Purified Anandamide-generating Phospholipase D as a Member of the Metallo-β-lactamase Family
resolves10.1042/bj20040031
Biosynthesis of anandamide and N-palmitoylethanolamine by sequential actions of phospholipase A2 and lysophospholipase D
resolves10.1074/jbc.M604660200
Endocannabinoid Biosynthesis Proceeding through Glycerophospho-N-acyl Ethanolamine and a Role for α/β-Hydrolase 4 in This Pathway
resolves10.1016/j.neuropharm.2007.05.020
Multiple pathways involved in the biosynthesis of anandamide
resolves10.1074/jbc.M606369200
Discovery and Characterization of a Ca2+-independent Phosphatidylethanolamine N-Acyltransferase Generating the Anandamide Precursor and Its Congeners
resolves10.1016/S0014-5793(97)01603-7
Anandamide amidohydrolase reacting with 2‐arachidonoylglycerol, another cannabinoid receptor ligand
resolves10.1124/jpet.302.1.73
Pharmacological Activity of Fatty Acid Amides Is Regulated, but Not Mediated, by Fatty Acid Amide Hydrolase in Vivo
resolves10.1074/jbc.272.43.27218
cDNA Cloning, Tissue Distribution, and Identification of the Catalytic Triad of Monoglyceride Lipase
resolves10.1523/JNEUROSCI.2419-04.2004
ATP Induces a Rapid and Pronounced Increase in 2-Arachidonoylglycerol Production by Astrocytes, a Response Limited by Monoacylglycerol Lipase
resolves10.1124/mol.104.002071
RNA Interference Suggests a Primary Role for Monoacylglycerol Lipase in the Degradation of the Endocannabinoid 2-Arachidonoylglycerol
resolves10.1016/j.chembiol.2005.04.013
Characterization of the Sulfhydryl-Sensitive Site in the Enzyme Responsible for Hydrolysis of 2- Arachidonoyl-Glycerol in Rat Cerebellar Membranes
resolves10.1038/nn1521
Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus
resolves10.1016/j.chembiol.2006.07.008
URB754 Has No Effect on the Hydrolysis or Signaling Capacity of 2-AG in the Rat Brain
resolves10.1038/nn0107-134a
Erratum: Selective inhibition of 2-AG hydrolysis enhances endocannabinoid signaling in hippocampus
resolves10.1038/sj.bjp.0706971
Lack of selectivity of URB602 for 2‐oleoylglycerol compared to anandamide hydrolysis <i>in vitro</i>
resolves10.1523/JNEUROSCI.4830-06.2007
Identification of a Novel Endocannabinoid-Hydrolyzing Enzyme Expressed by Microglial Cells
resolves10.1523/JNEUROSCI.4159-06.2007
Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus
resolves10.1016/j.chembiol.2007.11.006
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
resolves10.1002/cbic.200700139
Disulfiram is an Inhibitor of Human Purified Monoacylglycerol Lipase, the Enzyme Regulating 2‐Arachidonoylglycerol Signaling
resolves10.1038/nmeth778
A streamlined platform for high-content functional proteomics of primary human specimens
resolves10.1074/jbc.M200330200
Human Neuropathy Target Esterase Catalyzes Hydrolysis of Membrane Lipids
resolves10.1016/0014-5793(77)80099-9
Hormone‐sensitive lipase of rat adipose tissue: Identification and some properties of the enzyme protein
resolves10.1074/jbc.M007088200
Oxygenation of the Endocannabinoid, 2-Arachidonylglycerol, to Glyceryl Prostaglandins by Cyclooxygenase-2
resolves10.1038/nn1262
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus
resolves10.1016/j.neuropharm.2005.04.021
Endocannabinoids restrict hippocampal long-term potentiation via CB1
resolves10.1113/jphysiol.2007.137497
Roles of phospholipase Cβ and NMDA receptor in activity‐dependent endocannabinoid release
resolves10.1083/jcb.200305129
Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain
resolves10.1523/JNEUROSCI.0309-06.2006
Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses
resolves10.1523/JNEUROSCI.0054-06.2006
Localization of Diacylglycerol Lipase-α around Postsynaptic Spine Suggests Close Proximity between Production Site of an Endocannabinoid, 2-Arachidonoyl-glycerol, and Presynaptic Cannabinoid CB1 Receptor
resolves10.1523/JNEUROSCI.0448-07.2007
Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum
resolves10.1113/jphysiol.2005.091918
Depolarization‐induced suppression of excitation in murine autaptic hippocampal neurones
resolves10.1113/jphysiol.2006.119362
Depolarization‐induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2‐arachidonoylglycerol
resolves10.1152/jn.00813.2005
Multiple Mechanisms of Endocannabinoid Response Initiation in Hippocampus
resolves10.1016/j.neuropharm.2007.06.002
Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release
resolves10.1016/j.bbalip.2005.12.009
Development of the first potent and specific inhibitors of endocannabinoid biosynthesis
resolves10.1124/mol.107.037796
A Key Role for Diacylglycerol Lipase-α in Metabotropic Glutamate Receptor-Dependent Endocannabinoid Mobilization
resolves10.1124/mol.105.013961
Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors
resolves10.1016/j.neuron.2005.01.004
Phospholipase Cβ Serves as a Coincidence Detector through Its Ca2+ Dependency for Triggering Retrograde Endocannabinoid Signal
The 6 references without a DOI — listed, not checked
no DOI — not checkedBasic Neurochemistry
no DOI — not checkedThe Pharmacohistory of Cannabis sativa
no DOI — not checkedref49/cit49
no DOI — not checkedAhn, K.World Patent WO/2006/085196,2006.
no DOI — not checkedApodaca, R., Breitenbucher, J. G., Pattabiraman, K., Seierstad, M., and Xiao, W.World Patent WO 2006/074025,2006.
no DOI — not checkedMatsumoto, T., Kori, M., Miyazaki, J., and Kiyota, Y.WO 2006/054652,2006.
What this badge says. CiteStamped means the CHECKABLE references of this
work were clean at the dated check: each resolved to a known work in a public registry, and none
carried a retraction notice at that time. It says nothing about the quality, findings,
or importance of the work itself, and nothing about references deposited without a DOI.
checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record
Embed this badge
Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.
<a href="https://citestamp.com/citestamped/10.1021/cr0782067"><img src="https://citestamp.com/citestamped/10.1021/cr0782067/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[](https://citestamp.com/citestamped/10.1021/cr0782067)